iNova Pharmaceuticals has appointed Clemenger BBDO Sydney to handle its portfolio of brands that include Cough, Cold & Flu and Throat brands Duro-Tuss, Difflam and the Dermaveen therapeutic skincare range.
“It was a key priority for iNova to work with a strategic partner agency that could help us get under the skin of our consumers to make our brands stickier and more distinctive in people’s minds. Pete and his team have quickly demonstrated that they really ‘get’ our brands and importantly have shown they have the passion and expertise to deliver the transformational creativity we are seeking,” stated Steve Maidment, marketing director – consumer healthcare, iNova Pharmaceuticals.
“We are thrilled to deepen our engagement and involvement with Andrew Jenkin, Steve Maidment, Filomena Maiese and the team at iNova. We love the thirst for innovation and passion the team at iNova have to disrupt the category. We’ve relished the opportunity to work on the iconic Demazin brand and we look forward to building on the terrific partnership we have built with the team at iNova to deliver more great work together,” added Pete Bosilkovski, chief executive officer Clemenger BBDO Sydney.